Neoplasms

All Conditions

Skin and Connective Tissue Diseases

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Symptoms and General Pathology

Rare Diseases

Carcinoma

Melanoma

Carcinoma, Renal Cell

Neoplasm Metastasis

Remission, Spontaneous

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Neuroendocrine Tumors

Neuroectodermal Tumors

Neuroectodermal Tumors, Primitive

Neoplasms, Germ Cell and Embryonal

Neoplasms, Nerve Tissue

Nevus, Pigmented

Nevus

Nevi and Melanomas

Skin Neoplasms

Skin Diseases

Adenocarcinoma

Kidney Neoplasms

Urologic Neoplasms

Urogenital Neoplasms

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Kidney Diseases

Urologic Diseases

Male Urogenital Diseases

Disease Progression

Disease Attributes

Renal Cell Carcinoma

Clear Cell Renal Cell Carcinoma

Neuroendocrine Tumor

Neuroepithelioma

Patients must have metastatic melanoma or renal cell cancer with spontaneous regression.

Blood collection for laboratory studies

Clinical data such as demographics and cancer characteristics, history and treatment will be collected

Data collection from medical record

Theodore Logan, MD

The purpose of this study is to collect blood and clinical data from patients with metastatic melanoma and renal cell cancer who have experienced spontaneous regression for studies of immune response and other factors that may influence these occurrences.

Spontaneous regression in patients with metastatic cancer is an incredibly rare event. It has been described after infection in cancer patients and also rarely in patients with renal cell cancer (usually after resection of the renal primary) and, less commonly, in patients with metastatic melanoma.

Primary Objective To collect peripheral blood from patients with metastatic melanoma and renal cell cancer and spontaneous regression for studies of immune response and other studies.

Secondary Objective To collect clinical data from subjects registered to this study. Clinical data collection will include demographics and cancer characteristics, history and treatment.

Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma

Blood Drawing for Study of Peripheral Blood T-lymphocytes and Other Parameters in Patients With Metastatic Melanoma and Renal Cell Cancer With Spontaneous Regression

samples collected from metastatic melanoma and renal cell cancer patients

Indiana University

Associate Professor of Medicine

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma	NCT03728842	Melanoma; Renal...	Blood collectio... Data collection...	18 Years -	Indiana University
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma	NCT03728842	Melanoma; Renal...	Blood collectio... Data collection...	18 Years -	Indiana University

Spots Global Cancer Trial Database for blood collection for laboratory studies